Home › Funds › VERUS CAPITAL PARTNERS, LLC › ABBV

VERUS CAPITAL PARTNERS, LLC position in ABBV

ABBVIE INC · Health Care

VERUS CAPITAL PARTNERS, LLC reported holding 48,145 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$12.6M, representing 0.67% of its reported portfolio and ranking #26 among its reported holdings. VERUS CAPITAL PARTNERS, LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)48.15K sh
Reported value held$12.59M
Portfolio Weight0.67%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How VERUS CAPITAL PARTNERS, LLC's ABBV position evolved

VERUS CAPITAL PARTNERS, LLC first disclosed a stake in ABBV in Q3 2023 at 65,095 shares (US$9.7M). The position peaked in Q3 2025 at 56,531 shares, worth US$13.1M. Across 13 filings, VERUS CAPITAL PARTNERS, LLC increased the stake 1 time(s), trimmed it 10 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 48,145 shares valued at US$12.6M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 65.09K $9.70M New
Q4 2023 63.65K $9.86M Reduce
Q1 2024 64.64K $11.77M Add
Q2 2024 62.60K $10.74M Reduce
Q3 2024 61.97K $12.24M Reduce
Q4 2024 60.88K $10.82M Reduce
Q1 2025 58.78K $12.31M Reduce
Q2 2025 57.87K $10.74M Reduce
Q3 2025 56.53K $13.09M Reduce
Q4 2025 55.61K $12.71M Reduce
Q1 2026 53.14K $11.56M Reduce
Q2 2026 47.93K $12.06M Reduce
Q3 2026 48.15K $12.59M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has VERUS CAPITAL PARTNERS, LLC held ABBV?

VERUS CAPITAL PARTNERS, LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is VERUS CAPITAL PARTNERS, LLC's current position in ABBV?

As of Q3 2026, VERUS CAPITAL PARTNERS, LLC holds 48.15K shares of ABBV (ABBVIE INC), valued at $12.59M, representing 0.67% of its reported portfolio and ranking #26.

Has VERUS CAPITAL PARTNERS, LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), VERUS CAPITAL PARTNERS, LLC held unchanged its position in ABBV. The position peaked in Q3 2025 at 56.53K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.